Dotbio
Blood & Organ Banks · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
SingaporePhone Number
+65 69060743Website
www.dotbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Dotbio
Dotbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dotbio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Dotbio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Dotbio
Website visits: Recent activity has been detected on your website
Check if Dotbio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Dotbio had a recent Job posting/layoffs
Product Launch: Get notified when Dotbio launches new products
Dotbio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Dotbio is spiking on competitors!
Earning: See what the market has to say on Dotbio recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Dotbio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Dotbio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Dotbio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Dotbio.
Dotbio Tech Stack
A closer look at the technologies used by Dotbio
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dotbio
DotBio is a biopharmaceutical company that specializes in next-generation domain antibody therapies. Utilizing its proprietary DotBody technology platform, the company creates multi-functional and intracellular antibody therapies derived from stabilized human VH domains. DotBio's innovative approach allows for the rapid generation of bi- and tri-sp... Read More
